Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production
Cellular Oncology · 2024
DOI: 10.1007/s13402-024-01022-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Jing Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Pancreatic Neoplasms, Disease Progression, Carbonic Anhydrase IX. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
- Shanghai Pancreatic Cancer Institute, Shanghai, China.
- Pancreatic Cancer Institute, Fudan University, Shanghai, China.
- Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. xujin@fudanpci.org.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. xujin@fudanpci.org.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, J., Tong, X., Wang, W., Yu, X., Xu, J., & Shi, S. (2024). Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production. Cellular Oncology. https://doi.org/10.1007/s13402-024-01022-9
Vancouver
Yang J, Tong X, Wang W, Yu X, Xu J, Shi S. Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production. Cellular Oncology. 2024. doi:10.1007/s13402-024-01022-9
BibTeX
@article{Yang2024,
author = {Yang, Jing and Tong, Xuhui and Wang, Wei and Yu, Xianjun and Xu, Jin and Shi, Si},
title = {Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production},
journal = {Cellular Oncology},
year = {2024},
doi = {10.1007/s13402-024-01022-9}
}
EUVIMED